**Core Concept**
The question is testing the understanding of acute rejection in kidney transplant patients, specifically the immunological process involved. Acute rejection is a major complication in kidney transplantation, occurring when the immune system of the recipient recognizes the transplanted kidney as foreign and mounts an immune response against it.

**Why the Correct Answer is Right**
The patient's symptoms, including oliguria (reduced urine output), fever, hypertension, and pain or tenderness over the allograft, suggest an acute rejection episode. This is likely due to an immune response mediated by T cells and macrophages, which recognize the transplanted kidney as foreign and initiate an inflammatory response. The activation of T cells and macrophages leads to the release of various cytokines and chemokines, causing tissue damage and inflammation in the graft.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because chronic rejection is a slow and progressive process that occurs months to years after transplantation, rather than an acute event like the one described.
**Option B:** This option is incorrect because delayed graft function is a complication that occurs in the early post-transplant period, usually due to ischemia-reperfusion injury or other factors, but is not an immunological process.
**Option C:** This option is incorrect because BK virus nephropathy is a viral infection that can occur in kidney transplant patients, but is not an immunological process like acute rejection.

**Clinical Pearl / High-Yield Fact**
Acute rejection in kidney transplant patients can be prevented or treated with immunosuppressive medications, such as corticosteroids, calcineurin inhibitors, and mTOR inhibitors. Early recognition and treatment of acute rejection are critical to preventing graft loss and improving long-term outcomes.

**Correct Answer: C. Acute rejection**